Ignite Creation Date:
2024-05-05 @ 10:54 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01218477
Status:
COMPLETED
Last Update Posted:
2016-06-17
First Post:
2010-10-08
Brief Title:
Dasatinib Combination Therapy With the Smoothened SMO Inhibitor BMS-833923 in Chronic Myeloid Leukemia CML
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-08
First Submit QC Date:
October 8 2010
Study First Post Date:
2010-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-05-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-16
Last Update Post Date:
2016-06-17
Last Update Post Date Type:
ESTIMATED